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ABSTRACT 	
 Complex regional pain syndrome (CRPS) is a chronic neuropathic pain disorder 
characterized by both central and peripheral symptoms that can be debilitating in 
children. CRPS treatment typically consists of intensive physical, occupational, and 
psychological therapy with evidence supporting the efficacy of this approach. Among 
these outcomes, some patients report significant improvements in pain while others report 
no change. Identifying baseline predictors of treatment resistance would refine our 
treatment approach and provide additional targets for intervention.  
The current study examined baseline brain structure via cortical thickness and 
gray matter volume (GMV) in 29 pediatric CRPS patients enrolled in an intensive pain 
rehabilitation program. All participants underwent MRI using a high-resolution T1-
weighted sequence. Patients were categorized as pain treatment “responders” (n=19) or 
“non-responders” (n=10) based on change in reported pain levels from admission to 
follow up.  
		 vii 
Compared to treatment responders, non-responders demonstrated significantly 
less GMV in the bilateral nucleus accumbens p<0.05 and right: putamen p<0.01, 
pallidum p<0.05, and amygdala p<0.05. Furthermore, treatment non-responders exhibited 
significant cortical thickening in the left anterior insular cortex and medial frontal gyrus, 
and cortical thinning in the bilateral precentral gyrus and superior frontal gyrus; right: 
middle frontal gyrus, fusiform gyrus, inferior temporal gyrus, middle temporal gyrus, and 
anterior prefrontal cortex; and left: parahippocampal gyrus. 
Though we did see significant thinning of the primary motor cortex in treatment 
non-responders compared to responders, the majority of our findings were localized to 
regions associated with reward, motivation, learning, and emotion. We, therefore, 
postulate that treatment non-responders, when compared to responders, likely have an 
intrinsically reduced reward responsiveness, diminished motivation, and impaired 
learning, overall contributing to their negative treatment outcomes and chronification of 
pain.  In conclusion, these baseline differences overall suggest these regional 
morphometric alterations may potentially serve as predictors of treatment response in 
pediatric CRPS. Furthermore, these areas may also indicate possible targets for future 
treatment.    
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INTRODUCTION 	
Chronic pain is a major health issue that can affect all individuals, regardless of 
age, sex, or race, and severely impacts his or her daily life and functioning. A recently 
conducted study reports more than 25 million adults suffer from daily chronic pain in the 
United States alone (Nahin, 2015). Furthermore, within the past few decades, chronic 
pain has become increasingly prevalent in children and adolescents, with estimates 
ranging from 20% to 46% world-wide (Landry et al., 2015). This condition has now 
become one of the most common reasons for seeking medical care (Johannes, Le, Zhou, 
Johnston, & Dworkin, 2010). Therefore, it is imperative research continues to be done, so 
we can better understand the etiology and pathogenesis of chronic pain and translate 
these discoveries into more effective clinical care.   
Chronic Pain 
  Everyone is familiar with acute pain – the pain typically felt after an inciting 
event. Typically, an inflammatory reaction occurs after this injury and in response, our 
bodies activate several physiological healing processes. Soon, the pain dissipates and our 
bodies recover. However, this is not always the case. For many, rather, a transition is 
made and this acute pain now becomes chronic.  
Chronic pain, as a diagnosis, encompasses a variety of very different clinical 
conditions, from lower back pain to neuropathic conditions; however, a common 
characteristic is shared amongst them: a persistence of pain that significantly impairs 
daily functioning and quality of life (Gereau et al., 2014).  
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Brain Structural Alterations in Chronic Pain 
It was long thought that chronic pain was simply an extended form of acute pain – 
a result of persistent stimulation of the central pain system by prolonged/repetitive 
nociceptive input from sensitized nociceptors or irritated/damaged nerve fibers (Schmidt-
Wilcke, 2015). However, research now shows the central nervous system, rather, plays a 
significant role in this process through pain centralization (Schmidt-Wilcke, 2015). 
In recent years, revolutionary technological developments, notably in 
neuroimaging, have brought about significant advancements in chronic pain research and 
have allowed for further study of the structural and functional architecture of the human 
brain in the state of pain (Lee & Tracey, 2013), as well as particular brain metrics 
associated with pain vulnerability/persistence (Denk, McMahon, & Tracey, 2014). Using 
magnetic resonance imaging (MRI) and voxel-based morphometry (VBM), numerous 
groups have also studied the changes in brain structure across multiple different pain 
conditions, including pelvic pain, tension-type headache, post-traumatic headache, 
migraine, back pain, facial pain, complex regional pain syndrome (CRPS), and 
fibromyalgia (As-Sanie et al., 2012; Obermann et al., 2009; Schmidt-Wilcke, 
Ganssbauer, Neuner, Bogdahn, & May, 2008; Schmidt-Wilcke et al., 2006; Schmidt-
Wilcke et al., 2005; Schmidt-Wilcke et al., 2007) and have shown that when compared to 
healthy controls, chronic pain patients demonstrated gray matter (GM) alterations of 
several brain regions related to the pain. Some specific findings of these different studies 
have been inconsistent, though this is most likely due to the differences in the categories 
and etiologies of the various conditions examined (Cauda et al., 2014). However, in 
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general, two common trends have been shown across these various studies: 1) Regional 
decreases in gray matter in areas related to antinociception as well as pain modulation 
and perception, specifically the prefrontal cortex (PFC), cingulate cortex, orbitofrontal 
cortex (OFC), and insula (Apkarian et al., 2004; As-Sanie et al., 2012; Cauda et al., 2014; 
Fritz et al., 2016; Ivo et al., 2013; Kregel et al., 2015; Rocca et al., 2006; Schmidt-Wilcke 
et al., 2006; Schmidt-Wilcke et al., 2005; Valfre, Rainero, Bergui, & Pinessi, 2008). Gray 
matter increases in areas of the basal ganglia that have been shown to be involved in the 
integration of motor, emotional, autonomic, and cognitive responses to pain (Borsook, 
Upadhyay, Chudler, & Becerra, 2010), specifically the putamen and globus pallidus 
(Schmidt-Wilcke et al., 2006; Schmidt-Wilcke et al., 2007; Schweinhardt, Kuchinad, 
Pukall, & Bushnell, 2008). 
Furthermore, studies have also used neuroimaging to determine whether similar 
alterations in cortical thickness are observed in chronic pain patients, when compared to 
healthy controls. Similar to the findings from VBM analyses, there is no clear emergent 
pattern of results. For example, it appears that different chronic pain syndromes 
demonstrated have unique and specific alterations in cortical thickness (Schmidt-Wilcke, 
2015). Notwithstanding these differences, two trends emerged for across pain conditions: 
1) an increase in cortical thickness in the primary somatosensory cortex (DaSilva, 
Granziera, Snyder, & Hadjikhani, 2007; Labus et al., 2014) and 2) a decrease in the 
cortical thickness of structures involved in the salience network, antinociception, and 
pain modulation (Davis et al., 2008; Seminowicz et al., 2011). 
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Treatment Response   
New studies are emerging that examine brain-based predictors of treatment 
response in chronic pain patients. A recent study by Schmidt-Wilcke et al. (2014) used 
resting state functional MRI to study treatment response in fibromyalgia patients and 
found that patients who reported greater reductions in clinical pain scores were those who 
exhibited decreased baseline functional connectivity between pro-nociceptive regions and 
antinociceptive pain regions, specifically between the rostral part of the anterior cingulate 
cortex (rACC) and the insular cortex (IC), as well as between the periaqueductal gray 
(PAG) and the IC. This study strongly suggests that neuroimaging can serve as an 
important clinical tool in predicting treatment response (Schmidt-Wilcke et al., 2014).   
Transition from Acute to Chronic Pain 
Possible Neural Mechanisms 
In a similar manner, research has also been conducted to study the transition from 
acute to chronic pain in the hopes of discovering potential predictors of pain 
chronification. Baliki et al. (2012) examined this process in a chronic back pain 
population and found that when compared to healthy controls, patients exhibited 
longitudinal decrease in GM density in the basal ganglia, specifically the bilateral 
striatum encompassing the nucleus accumbens and extending into the caudate and 
putamen, insula, and left primary sensorimotor (S1/M1) cortex. In addition to structural 
changes, this group also used functional magnetic resonance imaging (fMRI) to examine 
functional differences between acute and chronic back pain patients and found that 
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chronicity of pain was able to be predicted by enhanced functional connectivity between 
the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAc) at baseline 
(Baliki et al., 2012). 
A neuroimaging study by Mansour et al. (2013) also examined this process of 
pain chronification in a chronic back pain population, as well. Using diffusion tensor 
imaging (DTI), they found that baseline regional decreases in white matter fractional 
anisotropy (FA) were accurate predictors of pain persistence (Mansour et al., 2013). 
Furthermore, they also found that local FA was correlated to functional connectivity 
between the mPFC and NAc; a positive correlation between local FA and functional 
connectivity was only seen in patients whose pain had subsided, and not in those whose 
pain persisted (Mansour et al., 2013).  
These studies suggest that prior existing alterations in brain structure and function 
are predictive of pain chronification and have both indicated the NAc as a major player in 
this process. Structurally, the NAc is part of the ventral striatum of the basal ganglia and 
functionally, it is involved in the mesolimbic pathway, specifically in reinforcement 
learning (Baliki et al., 2013), reward responsiveness (Elvemo, Landro, Borchgrevink, & 
Haberg, 2015), and motivation (Mogenson, Jones, & Yim, 1980). Like the two mentioned 
above, many other studies have also examined the role of NAc in chronic pain, both in 
humans and in animal models. Elvemo et al. (2015) used neuroimaging to demonstrate a 
significant positive partial correlation between reduced nucleus accumbens volume and 
lower reward responsiveness only in chronic pain patients and not healthy controls. This 
suggests that patients have a lower sensitivity to the occurrence or the anticipation of 
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reward and further implies this reduced reward responsiveness may be a marker of 
chronic pain vulnerability (Elvemo et al., 2015).  
Furthermore, a study by Schwartz et al. (2014) using mice of two different 
chronic pain models demonstrated that pain-induced synaptic adaption within the NAc 
contributed to the subjective impairment in the ability to initiate or sustain difficulty 
physical or mental tasks. In other words, pain-induced alterations in the NAc were 
associated with observable decreases in motivation.  
These studies mentioned above are only a minute subset of the incredible number 
of neuroimaging studies that have been conducted in recent years studying chronic pain. 
All of these studies have significantly contributed to our current knowledge of chronic 
pain and its potential neural mechanisms. However, as the majority of these studies have 
focused on diseases such as chronic back pain, our understanding of some chronic pain 
syndromes, especially CRPS, remains fairly limited.  
Complex Regional Pain Syndrome 
 Complex regional pain syndrome (CRPS) is a neuropathic disorder usually 
developed after an injury (Bruehl, 2010) and is characterized by continuing presence of 
pain that is disproportionate to the inciting event (Barad, Ueno, Younger, Chatterjee, & 
Mackey, 2014). There are two types of CRPS: CRPS-1 and CRPS-2. CRPS-1 occurs 
without a definable nerve lesion while CRPS-2 involves cases where definable nerve 
lesions do exist. Clinical presentation of CRPS typically consists of central symptoms, 
including allodynia, movement disorders, altered autonomic function, changes in space or 
localization perception, and reduced cognition and memory function (Apkarian et al., 
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2004; Birklein, O'Neill, & Schlereth, 2015; Birklein, Riedl, Sieweke, Weber, & 
Neundorfer, 2000; Libon et al., 2010; Maihofner, Neundorfer, Birklein, & Handwerker, 
2006; Moseley, 2005; Smith et al., 2011; van Hilten, 2010) as well as peripheral 
symptoms, such as spontaneous ongoing pain, abnormal responses to innocuous and 
noxious stimuli, swelling, and autonomic changes in the affected region (Birklein et al., 
2015; Harden et al., 2013). Furthermore, neglect-like symptoms, such as inattention and 
avoidance of using the affected limb, have also been reported (Galer, Butler, & Jensen, 
1995; Galer & Jensen, 1999; Punt, Cooper, Hey, & Johnson, 2013). 
 CRPS presents differently in adults than it does in children (Bayle-Iniguez et al., 
2015). In pediatrics, patients are more commonly female, though this predominance is 
less marked in adults (Low, Ward, & Wines, 2007). In adults, this typically presents in 
upper extremities, whereas in pediatric patients, lower extremities are more frequently 
affected (Rodriguez-Lopez, Fernandez-Baena, Barroso, & Yanez-Santos, 2015). In 
children, significant trauma is less often a precipitating event as it is in adults (Low et al., 
2007). Furthermore, studies have shown that children often make a complete recovery 
after treatment (Low et al., 2007), whereas most adults retain some disability after the 
symptoms have resolved (Rodriguez-Lopez et al., 2015). 
Neuroimaging correlates of CRPS 
 Adult CRPS. Neuroimaging research by Barad et al. (2014) has shown that adult 
CRPS patients, when compared to healthy controls, exhibit decreased GM volume in 
several pain-affect regions (e.g. dorsal insula, left orbitofrontal cortex, and several 
regions of the cingulate cortex), many of which are areas involved in the classic limbic 
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system (e.g. bilateral pregenual anterior cingulate complex and OFC). The authors argue 
that these differences in limbic system structures underlie dysregulated emotional 
processing of pain information in CRPS patients (Barad et al., 2014). Furthermore, 
patients exhibited increased GM in the bilateral dorsal putamen, which the authors 
suggest may be a result of compensatory actions against the continued nociceptive input, 
as well as in the right hypothalamus, which is likely driving the autonomic symptoms of 
CRPS (Barad et al., 2014).  
 Another study by Geha et al. (2008) also evaluated structural brain alterations in 
CRPS and found that CRPS patients exhibited regional GM atrophy in a single cluster 
encompassing the anterior region of the right insular cortex, the right ventral medial 
prefrontal cortex (VMPFC), and the right NAc, areas related to emotional, autonomic, 
and pain perception. Further the authors argue that this atrophy of the right anterior 
insular cortex (AIC) is likely indicative of pain duration and the autonomic and visceral 
symptoms demonstrated in CRPS while that of the right VMPFC is suggestive of poor 
emotional decision-making. 
 In addition to examining VBM gray matter alterations, studies have also 
investigated whether similar cortical thickness changes were demonstrated in this 
population. A recent study by Lee et al. (2015) found that CRPS patients demonstrated a 
significant decrease in the cortical thickness of two regions of the prefrontal cortex 
compared to their healthy peers, positing these morphological changes may contribute to 
the pathophysiology of CRPS. Specifically, the authors show significant thinning of the 
right dorsolateral prefrontal cortex (DLPFC), which they suggest is a possible cause of 
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the executive dysfunction and disinhibited pain perception demonstrated in CRPS, as 
well as the left VMPFC, an area involved in pain anticipation, which an important 
modulating factor of the transition from acute to chronic pain (Lee et al., 2015). 
Pediatric CRPS. As pediatric CRPS is becoming increasingly recognized, more 
research is being conducted to examine potential alterations in the neurocircuitry of youth 
with CRPS. Young patients with CRPS have been shown to exhibit reduced GM in pain-
related cortical regions, including areas involved in motor function, motor planning, and 
chronic pain processing, as well as the OFC and anterior midcingulate cortex (aMCC) 
(Erpelding, Simons, et al., 2014). The OFC, as mentioned earlier, is part of the limbic 
system and involved in the cognitive and affective evaluation of external stimuli 
(Kringelbach, 2005), as well as the coordination of goal-directed behavior (Schoenbaum, 
Roesch, Stalnaker, & Takahashi, 2009). Similarly, the aMCC is an area involved in 
controlling pain, cognition, and negative emotions and is thought to serve as a center at 
which negative events, such as pain, are evaluated and integrated (Shackman et al., 2011; 
Vogt, 2005). Together, these cortical structure alterations may be drivers of the altered 
emotional and cognitive regulation processes observed in these pediatric CRPS patients 
(Erpelding, Simons, et al., 2014). 
Erpeleding, Simons et al. (2014) also found significant GM alterations in 
subcortical areas, specifically in regions of the basal ganglia, including the caudate, 
putamen, and nucleus accumbens, as well as the amygdala, thalamus, and hippocampus 
compared to healthy controls. The authors suggest this decreased GM of the basal 
ganglia, specifically the caudate and putamen, may be indicative of altered pain 
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processing and related to the movement dysfunction exhibited by patients while the 
alterations in the NAc relate to the hedonic tone demonstrated in pediatric CPRS 
(Erpelding, Simons, et al., 2014). 
Furthermore, this study also examined structural brain and functional connectivity 
changes in pediatric CRPS before and after treatment and found cortical thickening in the 
DLPFC, significant regional increases in subcortical GM volume, and enhanced 
connectivity between the DLPFC and the PAG, which is suggestive of improved 
communication between pain inhibitory mechanisms (Erpelding, Simons, et al., 2014). 
Overall, these findings demonstrate that the structural and functional alterations in areas 
involved in sensation, emotion, cognition, and pain modulation that are induced in the 
pain state are able to be reversed with treatment.  
CRPS Treatment 
Although numerous studies have been conducted to examine the relative 
efficacies of various treatment methods used in CRPS management, there are still no 
universally accepted CRPS treatment models that have been established to date. Many of 
these studies have shown conservative management through multidisciplinary treatment 
involving psychotherapy, pharmacotherapy, and physical therapy to be the most 
efficacious treatment approach (Low et al., 2007). Furthermore, Simons et al. (2013) 
found that this treatment method led to far more significant increases in functioning when 
implemented in an intensive day hospital-like program rather than in an outpatient setting 
(Simons, Sieberg, Pielech, Conroy, & Logan, 2013). However, for some, even this 
multimodal treatment approach proves ineffective (Low et al., 2007), and many are 
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forced to try more invasive treatment methods, including spinal stimulation or drug 
infusion, TENS (transcutaneous electrical nerve stimulation), and sympathetic blockade 
under general anesthesia; although historically they have been used more so in the adult 
population, in recent years, they have increasingly been trialed in children and adolescent 
patients (Rodriguez-Lopez et al., 2015). 
Even with numerous different treatment approaches that have been extensively 
studied and have been proven to be efficacious, there are still many patients whose pain 
does not resolve. A recent investigation characterized trajectories of pain in patients 
predominantly diagnosed with neuropathic pain up to one year after intensive 
interdisciplinary pain rehabilitative treatment. Three groups emerged: treatment 
responders (30.6%; showing almost complete resolution of pain symptoms), partial 
responders (36.8%; significant improvement in pain levels with modest levels of 
continued pain), and nonresponders (32.6%; no improvement in pain over time). This 
study examined cognitive, affective, and behavioral factors associated with pain 
trajectory paths. At baseline, pain nonresponder patients reported higher pain levels, 
disability, pain catastrophizing, fear avoidance of activities, lower school functioning and 
lower readiness to change. Treatment responders who reported full pain relief emerged as 
younger and having lower levels of anxiety and depressive symptoms at baseline (Simons 
et al., in preparation). What remains unknown is the degree to which these cognitive, 
affective, and behavioral predictors of treatment nonresponse can be tied to underlying 
neural circuit dysfunction (Simons, Elman, & Borsook, 2014). While other chronic pain 
syndromes have been studied using functional imaging to discover predictors of 
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treatment response (Schmidt-Wilcke et al., 2014), no pediatric CRPS neuroimaging 
research has been done to compare treatment responders with non-responders to examine 
baseline brain-based differences that may drive these divergent treatment outcomes.  
Objectives  
  The data presented in this current study is part of a larger Institutional Review 
Board (IRB) approved fMRI imaging study conducted at Boston Children’s Hospital 
(BCH) evaluating (1) structural and functional differences between pediatric CRPS 
patients compared to matched healthy controls (Becerra et al., 2014; Erpelding, Sava, et 
al., 2014; Erpelding, Simons, et al., 2014) and (2) fear-related brain circuitry in patients 
(Simons et al., 2015; Simons, Pielech, et al., 2014). For the current analysis, we used the 
imaging data from structural MRI scans collected from patients prior to treatment, at 
“baseline.” Extensive chart review was conducted to obtain the patients’ reported 
subjective pain intensity scores at intake, discharge, and follow up to distinguish 
treatment responders from treatment non-responders. We then analyzed the imaging data 
acquired prior to treatment to determine whether treatment responders exhibit baseline 
structural differences compared to treatment non-responders. In doing so, we hope to use 
these structural differences as indicators of potential treatment response. With predictors 
such as these, additional targets can be found to further refine and individualize 
treatment.   
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Specific Aims 
The goals of this study are the following:  
1. Using reported subjective pain intensity scores at intake, discharge, and follow up, 
classify patients as either treatment responders or treatment non-responders. 
2. Analyze baseline structural MRI data to examine cortical thickness and 
subcortical gray matter volume differences between treatment responders and 
treatment non-responders. 
 
We hypothesize that our analysis will show: 
1. Based on the recent trajectory analysis, we anticipate that approximately 30-35% 
of patients will be categorized as treatment non-responders.  
2. Treatment responders exhibit a significant difference in baseline cortical GM 
thickness and subcortical GM volume in areas of emotion, learning, and 
motivation when compared to treatment non-responders.   
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METHODS 	
Study Participants 
Participants were first recruited from the Chronic Pain Clinic at the Pain 
Treatment Service (PTS) at Boston Children’s Hospital (BCH) in this IRB approved 
study. Patients who were then admitted to the Mayo Family Pediatric Pain Rehabilitation 
Center (PPRC) were enrolled in our study. The PPRC is an interdisciplinary rehabilitative 
program that involves intense psychological, physical, and occupational therapy; 
therapeutic recreation; and medical and nursing management.  
All participants were diagnosed with unilateral lower extremity CRPS and ranged 
in age from 8-20 years. Informed assent and consent was obtained from the patients and 
their parent(s), respectively. Parent(s) were present during the study visits. Each study 
session consisted of a neurological exam with a study physician, questionnaires, and a 
MRI scan. The MRI scans were conducted at the time of admission to the PPRC.  
Inclusion and Exclusion Criteria 
 Patients were included in this study if 1) they refrained from using analgesic 
medication >4 hours prior to the study session, 2) they experienced unilateral lower 
extremity CRPS (based on the Budapest criteria; Harden et al., 2010), and (3) their pain 
intensity was >5 on a 11-point numerical rating scale (NRS). They were excluded if they 
had 1) claustrophobia, 2) significant medical problems (e.g., uncontrollable asthma and 
seizures, cardiac diseases, severe psychiatric disorders, and neurological disorders other 
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than CRPS), 3) pregnancy, 4) medical implants and/or devices, and 5) weight > 285 
pounds, which corresponded to the weight limit of the MRI table.   
Cohort Determination 
 The patients were categorized into one of two cohorts, treatment responders or 
treatment non-responders, based on their reported subjective pain levels taken at PPRC 
admission, discharge, and 4-6 month follow up (see Table 1). Patients reported their 
overall pain intensity on an 11-point NRS (0 = no pain, 1-3 = mild pain, 4-6 = moderate 
pain, 7-10 = severe pain). Patients whose pain levels significantly decreased in severity 
from the time of intake to follow-up (e.g., severe to moderate, moderate to mild, mild to 
none, etc.) were categorized as treatment responders, whereas those whose pain levels 
either remained unchanged or increased after treatment were classified as treatment non-
responders. Additionally, patients who reported development of new pain symptoms in 
locations other than their CRPS-affected extremity were considered to be treatment non-
responders.  
 
Table 1 Cohort categorization guidelines 
 Treatment Responder Treatment Non-Responder 
Intake to follow up Significant decrease in pain 
severity  
No change or increase in pain severity 
After discharge No new of pain areas  Development of new pain symptoms 
in a different area  
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MRI Acquisition  
Subjects underwent MRI on a 3 Tesla (3T) scanner (Siemens Medical Solutions, 
Erlangen, Germany) using a 12-channel head coil. For each participant, we collected a 
3D T1-weighted anatomical scan using a magnetization-prepared rapid acquisition 
gradient echo (MPRAGE) sequence (128 slices; TR = 2100 ms; TE = 2.74 ms; TI = 1100 
ms; 256 × 256 matrix; FOV = 200 mm; 1.33 × 1.0 × 1.0 mm voxels). Subjects were 
instructed to relax with their eyes open looking at a blank screen.  
MRI Preprocessing and Data Analysis  
Cortical thickness 
Cortical thickness analysis, which was done at the whole brain level, was 
performed using FreeSurfer (http://surfer.nmr.mgh.harvard.edu) in order to examine 
whether treatment responders exhibited baseline cortical GM differences compared to 
treatment non-responders. MPRAGE preprocessing steps included the following: 1) 
intensity normalization, 2) skull stripping, 3) Talairach transformation, 4) hemispheric 
separation, 5) tissue segmentation, 6) identification of white surface and pial surface, 7) 
cortical parcellation, 8) registration to the average surface map, and lastly 9) application 
of a 10-mm full-width half-maximum (FWHM) Gaussian smoothing kernel. Results were 
corrected for multiple comparisons based on Monte Carlo permutations with 5,000 
iterations using AlphaSim (http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim). Using 
an image-wide threshold of p < .01 and a Bonferroni-corrected p < 0.025 (to correct for 
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each hemisphere), AlphaSim simulations revealed that 76 contiguous vertices were 
required for clusters to be significant.  
Subcortical Volume 
 In order to determine whether treatment responders exhibit baseline subcortical 
GM volume differences compared to treatment non-responders, whole structure 
subcortical volumes were derived using FreeSurfer processing stream (aseg stats).  For 
each subject, total intracranial volume (TIV) was extracted and entered as a variable of 
no interest for subcortical GM volume in order to control for variability in head size.  
Statistical Analysis  
FreeSurfer automated segmentation was fed into Statistical Package for the Social 
Sciences (SPSS) (www.ibm.com/software/analytics/spss) software to correlate with both 
cortical thickness and subcortical volumes, excluding outliers and controlling for TIV for 
subcortical GM only. 
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RESULTS 	
Study Participants 
 A total of 29 CRPS patients were included for subcortical gray matter volume and 
cortical thickness analysis. They ranged in age from 8-20 years (mean ± SD = 13.5 ± 2.6 
years) and were mostly female (72%) All patients were right-handed. Using the cohort 
determination criteria outlined above (Table 1), 19 patients were categorized treatment 
responders and 10 were non-responders (65.5% treatment responders, 34.5% treatment 
non-responders).   
 Of note, subsamples of this study population have previously been used. The 
alterations in functional connectivity between specific brain regions (e.g. habenula, 
amygdala) to the rest of the brain were studied within this population (Erpelding, Sava, et 
al., 2014; Simons et al., 2015; Simons, Pielech, et al., 2014), as well as changes in brain 
structure (Erpelding, Simons, et al., 2014). Of note, Erpelding, Simons et al. flipped half 
the patients’ brains to control for the affected side during structural analysis, specifically 
to investigate whether the somatosensory and motor cortices of the brain, areas in which 
laterality has been shown to act as a confounding variable, were significantly impacted by 
the disease state (Erpelding, Simons, et al., 2014). 
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Table 2 Study participant clinical history and corresponding responder status 
ID 
Area of 
Pain 
Reported Pain Levels at: 
Complicating 
Factors 
Responder 
or Non-
responder Admission Discharge 
Follow 
Up 
S002 RLE 7/10 6.5/10 6/10 
1 month after 
discharge: right hip 
pain 
Non-
Responder 
S003 LLE 3/10 1-2/10 0/10  Responder 
S006 BLE 7/10 5-8/10 7-9/10 
1 month after 
discharge: memory 
loss, headaches, 
lower extremity 
paralysis, 
conversion disorder 
Non-
responder 
S010 
R Ankle 
R Knee 
7/10 
7/10 
0/10 
3/10 
0/10 
3/10 
 Responder 
S012 LLE 5-7/10 0/10 0/10  Responder 
S014 LLE 2-3/10 2/10 0/10  Responder 
S015 LLE 6/10 2/10 1/10  Responder 
S016 LLE 9-10/10 7.5/10 8-9/10 
2 months after 
discharge: 
depression and 
suicidal ideation 
Non-
Responder 
S017 BLE 4/10 0/10 0/10  Responder 
S018 RLE 6/10 5.5/10 6/10 
2 months after 
discharge: right hip 
pain 
Non-
Responder 
S019 LLE 5-6/10 7-8/10 1/10 
4 months after 
discharge: chronic 
migraines, back 
pain, vertigo, loss 
of consciousness, 
conversion disorder 
Non-
Responder 
S101 BLE 8/10 6-7/10 0/10  Responder 
Abbreviations: BLE (bilateral lower extremity), LLE (left lower extremity), R (right) RLE 
(right lower extremity) 
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Table 2 cont.  Study participant clinical history and corresponding responder status 
ID 
Area of 
Pain 
Reported Pain Levels at: 
Complicating 
Factors 
Responder 
or Non-
responder Admission Discharge 
Follow 
Up 
S110 RLE 7/10 8/10 0/10  Responder 
S115 L Knee 4/10 3/10 5-6/10  
Non-
Responder 
S121 
RUE 
RLE 
4/10 
3/10 
1/10 
2/10 
0/10 
0/10 
 Responder 
S122 LLE 8/10 6/10 5/10  Responder 
S124 RLE 7/10 5/10 0/10  Responder 
S125 LLE 9/10 8/10 3/10  Responder 
S127 LLE 6/10 7/10 3/10  Responder 
S128 RLE 7/10 5/10 0/10  Responder 
S132 LLE 4/10 3/10 1/10  Responder 
S133 LLE 6/10 2/10 0/10  Responder 
S140 BUE, BLE 8/10 8/10 9/10 
Development of 
facial pain and skin 
pain at site of 
walking aid 
Non-
Responder 
S150 R foot 4/10 6/10 6/10  
Non-
Responder 
S157 
L foot 
Headache 
7/10 
4/10 
0/10 
0/10 
0/10 
0/10 
 Responder 
S158 
RLE 
BUE 
3/10 
3/10 
6/10 
0/10 
0/10 
0/10 
 Responder 
S161 LLE 4/10 1/10 1/10  Responder 
S170 RLE 3/10 4/10 8/10 
Does not engage in 
follow up PT 
sessions  
Non-
Responder 
Abbreviations: BLE (bilateral lower extremity), BUE (bilateral upper extremity),  
L (left), LLE (left lower extremity), R (right),  RLE (right lower extremity, RUE (right upper 
extremity) 
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Subcortical Volume 
 Compared to treatment responders, treatment non-responders demonstrated 
significantly less GM volume in the bilateral nucleus accumbens p<0.05 and right: 
putamen p<0.01, pallidum p<0.05, and amygdala p<0.05. We did not find any subcortical 
areas in which the treatment non-responders demonstrated significant greater GM volume 
when compared to treatment responders (Table 3).  
 
 
Table 3 Subcortical gray matter differences between treatment responders and 
treatment non-responders 
Brain Region Treatment Responder 
Mean ± SD 
Treatment Non-Responder 
Mean ± SD 
P 
Subcortical Volume    
Left Hemisphere    
Nucleus Accumbens 668.84 ± 101.50 574.50 ± 74.89 .024 
    
Right Hemisphere    
Putamen 6511.37 ± 582.95 5822.10 ± 476.31 .006 
Pallidum 1917.79 ± 216.40 1701.40 ± 135.00 .012 
Amygdala  1840.37 ± 240.47 1597.60 ± 156.61 .010 
Nucleus Accumbens 799.63 ± 86.38 707.00 ± 97.06 .018 
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Cortical Thickness 
 When compared to treatment responders, treatment non-responders exhibited 
significantly reduced cortical thickness in the left: posterior parahippocampal gyrus 
(pPHG), anterior parpahippocampal gyrus (aPHG), superior frontal gyrus (SFG), 
precentral gyrus (preCG), and lateral occipital cortex (LOCC); and right: middle frontal 
gyrus (MFG), fusiform gyrus (FFG), inferior temporal gyrus (ITG), anterior prefrontal 
cortex (aPFC), middle temporal gyrus (MTG), precentral gyrus (preCG), occipital pole 
(OcPo), lateral occipital cortex (LOCC), and superior frontal gyrus (SFG). There were 
two regions in which treatment non-responders exhibited significantly increased cortical 
thickness: the left anterior insular cortex (AIC) and medial frontal gyrus (mFG).  
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Table 4 Cortical thickness differences between treatment responders and treatment 
non-responders  
Brain Region Vertices/Voxels 
MNI Coordinates 
T 
X Y Z 
Cortical Thickness      
Left Hemisphere      
Treatment Non-Responder < Treatment Responder      
Posterior parahippocampal gyrus  1095 -27 -30 -22 4.25 
Anterior parahippocampal gyrus 636 -24 -1 -31 4.14 
Superior frontal gyrus 223 -15 54 24 4.06 
Precentral gyrus 144 -20 -7 55 2.88 
Lateral occipital cortex 120 -18 -86 37 2.86 
      
Treatment Non-Responder > Treatment Responder      
Anterior insular cortex 148 -29 18 6 -2.86 
Medial frontal gyrus 127 -22 41 25 -3.01 
      
Right Hemisphere      
Treatment Non-Responder < Treatment Responder      
Middle frontal gyrus 283 40 4 49 2.88 
Fusiform 259 35 -5 -36 3.46 
Inferior temporal gyrus 156 53 -16 -25 2.52 
Fusiform 140 35 -41 -17 2.92 
Anterior prefrontal cortex 103 19 55 20 2.44 
Middle temporal gyrus 101 50 5 -35 2.53 
Precentral gyrus 101 15 -14 63 2.37 
Occipital pole 96 19 -97 16 2.54 
Lateral occipital cortex 89 44 -66 31 2.7 
Superior frontal gyrus 89 14 3 63 2.45 
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Figure 1 Significant left hemisphere cortical thickness differences between 
treatment responders and treatment non-responders: lateral surfaces. Compared to 
treatment responders, treatment non-responders demonstrated less cortical GM in brain 
regions including the anterior parahippocampal gyrus (aPHG), posterior parahippocampal 
gyrus (pPHG), precentral gyrus (PreCG), superior frontal gyrus (SFG), and lateral 
occipital cortex (LOCC), and increased cortical GM in in the medial frontal gyrus (mFG) 
and anterior insular cortex (AIC). 					
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Figure 2 Significant left hemisphere cortical thickness differences between 
treatment responders and treatment non-responders: anterior/posterior. Compared 
to treatment responders, treatment non-responders demonstrated less cortical GM in brain 
regions including the anterior parahippocampal gyrus (aPHG), posterior parahippocampal 
gyrus (pPHG), precentral gyrus (PreCG), superior frontal gyrus (SFG), and lateral 
occipital cortex (LOCC), and increased GM in the medial frontal gyrus (MFG) 						
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Figure 3 Significant right hemisphere cortical thickness differences between 
treatment responders and treatment non-responders: lateral surfaces. Compared to 
treatment responders, treatment non-responders demonstrated less cortical GM in brain 
regions including the fusiform gyrus (FFG), middle frontal gyrus (MFG), precentral 
gyrus (PreCG), inferior temporal gyrus (ITG), middle temporal gyrus (MTG), and lateral 
occipital cortex (LOCC). 							
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Figure 4 Significant right hemisphere cortical thickness differences between 
treatment responders and treatment non-responders: anterior/posterior. Compared 
to treatment responders, treatment non-responders demonstrated less cortical GM in brain 
regions including the occipital pole (OcPo), lateral occipital cortex (LOCC), superior 
frontal gyrus (SFG), middle frontal gyrus (MFG), anterior prefrontal cortex (AFG), and 
middle temporal gyrus (MTG) 																	
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aPFC&
MTG&
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DISCUSSION 	
Subcortical Gray Matter Differences between CRPS Treatment Responders and 
Treatment Non-Responders 
 We identified several brain regions in which treatment non-responders 
demonstrated significant morphologic differences when compared to treatment 
responders. The subcortical areas in which the non-responders exhibited less gray matter 
volume than the responders included the bilateral nucleus accumbens and the right 
putamen, pallidum, and amygdala. Several of these regions (nucleus accumbens, 
putamen, and pallidum) are structures involved in the basal ganglia.  
 The basal ganglia plays a significant role in motor function such that 
diseases/lesions of these regions have been shown to lead to movement disorders with 
associated changes in motor function (Crossman, 1987; Herrero, Barcia, & Navarro, 
2002). Several medical conditions with considerable motor components, including 
Parkinson’s disease and Huntington’s disease, all exhibit alterations in the basal ganglia 
(Blaszczyk, 1998; Graveland, Williams, & DiFiglia, 1985). However, the functions of 
regions of the basal ganglia are not limited to those related to movement; they have also 
been shown to be critical areas involved in reward and motivation (Morita & Hikida, 
2015; Robbins & Everitt, 1996; Schultz, Tremblay, & Hollerman, 1998). Furthermore, 
studies have shown that these two seemingly different functions of movement and reward 
processing are actually quite closely connected (Catanese & van der Meer, 2013; 
Pasquereau et al., 2007), which suggests the basal ganglia serves to integrate these two 
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actions in higher-level functions of goal-directed behavior and habit learning (Goldstein 
et al., 2012; Hikosaka, Kim, Yasuda, & Yamamoto, 2014).  
 Of the various structures that comprise the basal ganglia, the nucleus accumbens, 
the center at which motivational limbic inputs interface with motor outputs, has been 
shown to be an especially important structure in this process (Gale, Shields, Ishizawa, & 
Eskandar, 2014; Mogenson et al., 1980). This area, as mentioned before, has been 
examined in various chronic pain conditions and has been shown to exhibit altered 
structural and functional properties in patients with chronic pain when compared to their 
healthy peers. They have argued that this decrease in reinforcement learning, reward 
responsiveness, and motivation contribute to the chronification of pain. Therefore, our 
findings of less subcortical volume in these regions of the basal ganglia, especially of the 
nucleus accumbens, suggest a baseline dysfunction of these areas. Treatment non-
responders, when compared to treatment responders, likely have an intrinsically reduced 
reward responsiveness, diminished motivation, and impaired learning, overall 
contributing to their negative treatment outcomes and chronification of pain.  
 The amygdala has long been known to be an important structure involved in fear 
conditioning, a type of emotional learning, (Bechara et al., 1995) and storage of aversive 
memories (Rodrigues, Schafe, & LeDoux, 2004). However, recent research has begun to 
elucidate its other functions, including those related to emotional processing (Costafreda, 
Brammer, David, & Fu, 2008; Phelps & LeDoux, 2005), reward, motivation, and learning 
(Baxter & Murray, 2002; Murray, 2007). Several studies have shown that the amygdala, 
through its extensive connections with the nucleus accumbens, is a critical structure in the 
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reward-learning process, as can be seen by impairments in this behavior with lesions to 
the amygdala (Cador, Robbins, & Everitt, 1989; Gallagher, Graham, & Holland, 1990). 
Furthermore, the amygdala has also been shown to be involved in chronic pain, 
specifically in pain processing, modulation, and the emotional responses to pain 
(Neugebauer, Li, Bird, & Han, 2004). Alterations in amygdala volume and function have 
been reported in various chronic pain syndromes, including pediatric CRPS (Burgmer et 
al., 2009; Erpelding, Simons, et al., 2014; Mao & Yang, 2015; Rodriguez-Raecke, 
Niemeier, Ihle, Ruether, & May, 2009). Our finding of decreased gray matter volume of 
the amygdala, therefore, suggests treatment non-responders demonstrate a baseline 
disruption in pain modulation and associated emotional processing. Thus, treatment 
responders are at an innate advantage, as they do not exhibit such impeding factors to 
their treatment and recovery.  
Differences in Cortical Thickness between CRPS Treatment Responders and 
Treatment Non-Responders 
 Treatment non-responders exhibited significantly reduced GM in several cortical 
areas compared to treatment responders, including the bilateral precentral gyrus (preCG), 
superior frontal gyrus (SFG), and lateral occipital cortex (LOCC); left posterior and 
anterior parahippocampal gyrus (pPHG, aPHG); and right middle frontal gyrus (MFG), 
fusiform gyrus (FFG), inferior temporal gyrus (ITG), anterior prefrontal cortex (aPFC), 
middle temporal gyrus (MTG), and occipital pole (OcPo). There were two regions in 
which treatment non-responders demonstrated increased cortical GM: the left anterior 
insular cortex (AIC) and medial frontal gyrus (mFG).  
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 Many of these cortical regions have previously been reported to be involved in 
various aspects of several different pain syndromes. These areas include the preCG, 
MFG, SFG, mFG, PHG, PFC, AIC.  
Of these cortical structures, the preCG is the only region that has been specifically 
shown to be associated with motor function. This may be due to the fact that the primary 
motor cortex (M1), an area essential for voluntary control of movement lies within this 
region. Alterations in its organization and function have been demonstrated in several 
different pain disorders, including low back pain (Tsao, Galea, & Hodges, 2008), 
neuropathic pain (Lefaucheur, Drouot, Menard-Lefaucheur, Keravel, & Nguyen, 2006), 
and CRPS. Specifically, in CRPS, functional and structural studies have found bilateral 
disinhibition of the motor cortex and alterations in its cortical GM in patients when 
compared to controls, suggesting this area’s involvement in the motor symptoms 
exhibited by patients, including weakness, allodynia, dystonia and myoclonia, reduced 
range in motion, and tremor (Erpelding, Simons, et al., 2014; Kirveskari, Vartiainen, 
Gockel, & Forss, 2010; Maihofner et al., 2007; Schwenkreis et al., 2003). Our results of 
altered GM in the precentral gyrus are in line with these previously reported findings and 
further indicate this area’s role in the motor dysfunction exhibited in CRPS.  
Several of the other cortical areas that we found to be significantly different 
between treatment responders and treatment non-responders have previously been 
associated with pain modulation. The MFG, SFG, and mFG were all reported to be 
positively associated with frontal pain-modulation in headache patients (Yang et al., 
2013). 
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 Similarly, the PHG has also been shown to be involved in pain modulation; 
however, unlike these other areas, the PHG has been found to function specifically in the 
emotional modulation of pain (Roy, Piche, Chen, Peretz, & Rainville, 2009). 
Furthermore, research has shown that it also related to pain sensitivity (Grant, 
Courtemanche, Duerden, Duncan, & Rainville, 2010). Therefore, increased activity of 
this area is associated with increased mediation of the negative affect related to pain and, 
therefore, increased pain modulation (Apkarian, Bushnell, Treede, & Zubieta, 2005), and 
negatively correlated to pain sensitivity. Therefore, our findings of reduced cortical GM 
in the parahippocampal gyrus suggests that compared to treatment responders, the non-
responders are more sensitive to pain and less able to modulate their subsequent 
emotional responses. 
Another area shown to be involved in the affective dimension of pain is the SFG 
(Fulbright, Troche, Skudlarski, Gore, & Wexler, 2001). This area was first thought to be 
involved in cognition (Li et al., 2013), introspection (Goldberg, Harel, & Malach, 2006), 
and working memory (du Boisgueheneuc et al., 2006). However, recent studies found 
morphometric alterations of this area in various pain syndromes, suggesting its 
involvement in pain processing (Bonaz et al., 2002; Vartiainen et al., 2009). A recent 
meta-analysis by Smallwood et al., (2013) further argues the SFG, through its various 
functions, as outlined above, is likely involved in coping and, therefore, acts in mediating 
one’s cognitive attempts to cope with pain. In line with these arguments, our data shows 
that treatment non-responders may have a dampened capability to process and cope with 
their pain.  
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The AIC is also related to affective pain processing and pain anticipation (Jensen 
et al., 2016; Koyama, McHaffie, Laurienti, & Coghill, 2005). Several studies have found 
significant alterations in AIC structure, with the majority of them reporting regional 
decreases in GM in patients compared to controls (Fritz et al., 2016; Geha et al., 2008). 
Recent studies examining the AIC’s role in pain anticipation demonstrated that 
prestimulus activation of the anterior insula was positively associated with increased pain 
perception (Wiech et al., 2010). Though our findings of increased AIC GM are not 
consistent with previous studies relating atrophy of this region to aberrant pain 
processing, it can be suggested that increased baseline activation of this area in treatment 
non-responders may correlate to increased subjective severity of pain.  
 Amongst all the cortical areas we found to be significant in our study, the aPFC 
was the most enigmatic. Many studies have investigated the role of the PFC in CRPS to 
find significant alterations in its structure and function correlated to the executive 
dysfunction and disinhibited pain perception in patients. However, all of these findings 
were localized to the DLPFC, VMPFC, and VLPFC (Barad et al., 2014; Geha et al., 
2008; D. H. Lee et al., 2015; Pleger et al., 2014). An extensive review of the literature 
produced a very limited number of articles specifically studying the aPFC and its 
function, of which only a small minority discussed its potential involvement in pain. 
Furthermore, of these studies, only ne reported full activation of this area during late 
painful stimulation, positing a negative correlation with pain unpleasantness (Lopez-Sola 
et al., 2010). Interestingly, however, the other studies examining aPFC function outlined 
its involvement in cognition, reward, learning, and decision making. A study by Scholl et 
	34 
al. (2015) found that aPFC activity is related to suppression of irrelevant reward 
information for more optimal learning and decision making. Furthermore, Kovach et al. 
(2012) argue that the aPFC functions to select and update models of reward contingency 
in dynamic environments. Therefore, our findings of reduced aPFC GM volume may 
suggest that treatment non-responders experience more difficulty using what they learn 
from recent experiences in helping them accurately decide which of their options offer 
the most reward/best outcome. For example, this may have meant that treatment 
responders saw benefit from what they learned in treatment and subsequently applied it to 
their everyday lives; non-responders may have experienced this similar benefit, but rather 
than choosing to apply what they learned in treatment to their daily activities, their 
behaviors were shaped by their previous reward history.  
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CONCLUSION 	
 In summary, we found significant regional cortical and subcortical differences in 
CRPS treatment non-responders compared to treatment responders. Some of these 
regions have previously been reported in chronic pain studies; however, interestingly, the 
majority of the brain areas we identified in our analysis are those related to emotion, 
reward, motivation, and learning. Therefore, we postulate that baseline impairments of 
these processes inhibited non-responders from achieving successful treatment responses. 
Furthermore, we propose that these regional morphometric alterations can potentially 
serve as predictors of treatment response.  
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IMPLICATIONS AND FUTURE DIRECTIONS 	
 Our findings show significant baseline differences in several brain regions related 
to emotion, reward, learning, and motivation between treatment non-responders and 
treatment responders. This implies that neuroimaging done at the beginning of treatment 
can potentially determine whether a certain patient will or will not be a successful 
responder.  
 There has been a recent shift in pain management towards a more personalized 
approach. It has been proposed that one’s genetic coding predisposes him/her to a certain 
sensitivity to pain (Manworren, 2015); therefore, individualized treatment would be able 
successfully combat those specific issues. Our study’s findings further support this idea. 
With these results, in the future, treatment approaches may potentially be tailored 
depending on a patient’s baseline impairments in emotional processing, reward, learning, 
and motivation. Or alternatively, treatment can first be targeted to these specific in hopes 
to normalize these processes, so that these patients are more inclined to have more 
successful treatment responses.  
 Although these findings have great implications for future treatment, our study is 
the first to implicate these regions in predicting treatment response. In order to validate 
these findings, additional neuroimaging studies must be conducted examining predictors 
of treatment response. These studies do not need to be limited to CRPS, but can examine 
if these findings can be replicated in other chronic pain syndromes. Furthermore, though 
our study restricted our analysis to structural alterations, future studies can further 
examine whether treatment non-responders exhibit altered function and connectivity in 
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these regions compared to treatment responders. Additionally, to allow these findings to 
be more generalizable, studies would have to be done not only in pediatric populations, as 
our study, but also in adult populations as well. With the findings from these additional 
studies, we hope our hypothesis suggesting that baseline alterations may potentially serve 
as treatment predictors will be robustly confirmed.  
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